Sun Pharmaceutical Industries Ltd — Tobramycin Exporter Profile
Indian Pharmaceutical Exporter · #11 for Tobramycin · $800.0K export value · DGFT Verified
Sun Pharmaceutical Industries Ltd is the #11 Indian exporter of Tobramycin with $800.0K in export value and 16 verified shipments. Sun Pharmaceutical Industries Ltd holds a 2.0% market share in Tobramycin exports across 2 countries.
Sun Pharmaceutical Industries Ltd — Tobramycin Export Profile: Buyers & Destinations
Where Does Sun Pharmaceutical Industries Ltd Export Tobramycin?
| Country | Value | Shipments | Share |
|---|---|---|---|
| BELGIUM | $2.4M | 62 | 63.2% |
| UNITED STATES | $1.0M | 23 | 28.1% |
| AUSTRALIA | $300.0K | 6 | 8.1% |
| RUSSIA | $25.5K | 2 | 0.7% |
Sun Pharmaceutical Industries Ltd exports Tobramycin to 4 countries. The largest destination is BELGIUM accounting for 63.2% of Sun Pharmaceutical Industries Ltd's Tobramycin shipments, followed by UNITED STATES (28.1%) and AUSTRALIA (8.1%). These destinations reflect Sun Pharmaceutical Industries Ltd's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Tobramycin from Sun Pharmaceutical Industries Ltd?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| YUSEN LOGISTICS BENELUX BELGIUM | BELGIUM | $1.8M | 47 |
| YUSEN LOGISTICS BENELUX BELGIUM KEETBERGLAAN | BELGIUM | $595.8K | 15 |
| SUN PHARMACEUTICAL INDUSTRIES,INC. | UNITED STATES | $534.8K | 11 |
| SUN PHARMA ANZ PTY LTD | AUSTRALIA | $300.0K | 6 |
| SUN PHARMACEUTICAL INDUSTRIES INC | UNITED STATES | $250.0K | 5 |
| SUN PHARMACEUTICAL INDUSTRIES, INC. | UNITED STATES | $169.6K | 4 |
| SUN PHARMACEUTICAL INDUSTRIES,INC, | UNITED STATES | $50.0K | 1 |
| SUN PHARMACEUTICAL INDUSTRIESINC. | UNITED STATES | $41.6K | 2 |
| AO "RANBAXY" | RUSSIA | $17.4K | 1 |
| AO RANBAXY - | RUSSIA | $8.1K | 1 |
Sun Pharmaceutical Industries Ltd supplies Tobramycin to 10 buyers globally. The largest buyer is YUSEN LOGISTICS BENELUX BELGIUM (BELGIUM), followed by YUSEN LOGISTICS BENELUX BELGIUM KEETBERGLAAN (BELGIUM) and SUN PHARMACEUTICAL INDUSTRIES,INC. (UNITED STATES). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Tobramycin Export Value and How Much Does Sun Pharmaceutical Industries Ltd Contribute?
India exported $20.8M worth of Tobramycin through 2,676 shipments from 283 suppliers to 134 countries, serving 580 buyers globally. Sun Pharmaceutical Industries Ltd contributes $800.0K to this total, accounting for 2.0% of India's Tobramycin exports. Sun Pharmaceutical Industries Ltd ships Tobramycin to 4 countries through 10 buyers.
What Is the Average Shipment Value for Sun Pharmaceutical Industries Ltd's Tobramycin Exports?
Sun Pharmaceutical Industries Ltd's average Tobramycin shipment value is $50.0K per consignment, based on 16 shipments totaling $800.0K. The largest destination is BELGIUM (63.2% of Sun Pharmaceutical Industries Ltd's Tobramycin exports).
How Does Sun Pharmaceutical Industries Ltd Compare to Other Indian Tobramycin Exporters?
Sun Pharmaceutical Industries Ltd ranks #11 among 283 Indian Tobramycin exporters with a 2.0% market share. The top 3 exporters are MANKIND PHARMA LIMITED ($3.9M), SUN PHARMACEUTICAL INDUSTRIES LIMITED ($3.9M), SENTISS PHARMA PRIVATE LIMITED ($3.0M). Sun Pharmaceutical Industries Ltd processed 16 shipments to 2 destination countries.
What Tobramycin Formulations Does Sun Pharmaceutical Industries Ltd Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| TOBRAMYCIN SUN 300MG/5MLNEBULIZER SOLUTI | $641.4K | 18 |
| TOBRAMYCIN SUN 300MG/5ML NEBULIZER SOLUT | $289.3K | 8 |
| TOBRAMYCIN SUN 300MG/5ML NEBULIZER SOLUTION TOBRAMYCIN 300MG/5ML NEBULISER SOLUTION [351 PACK X 4 X 14 = 19656 NOS] | $269.7K | 6 |
| Tobramycin Inhalation Solution USP, 300 | $200.0K | 4 |
| TOBRAMYCIN INHALATION SOLUTION USP 300 | $200.0K | 4 |
| TOBRAMYCIN SUN 300MG/5ML NEBULIZER SOLUTION TOBRAMYCIN 300MG/5ML NEBULISER SOLUTION [475 PACK X 4 X 14 = 26600 NOS] | $150.0K | 3 |
| TOBRAMYCIN SUN 300MG/5ML SOLUTION FOR INHALATION (TOBRAMYCIN 300MG/5ML NEBULISERSOLUTION) [1000 PACK X 4X14 =56000 NOS]NOS | $150.0K | 3 |
| TOBRAMYCIN INHALATION SOLUTION USP, 300MG/5 ML PACK : 04*14 BATCH : BAE0386A/BAE0378A MFD : 30.11.2023/28.11.2023 EXP :NOS | $149.4K | 3 |
| TOBRAMYCIN INHALATION SOLUTION USP,300 M | $100.0K | 2 |
| TOBRAMYCIN SUN 300MG/5MLNEBULIZER SOLUTION (FOR FRANCE) / TOBRAMYCIN 300 MG/5 MLNEBULISER SOLUTION BP (For EU) PACK: 04 | $100.0K | 2 |
Sun Pharmaceutical Industries Ltd exports 41 distinct Tobramycin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is TOBRAMYCIN SUN 300MG/5MLNEBULIZER SOLUTI with 18 shipments worth $641.4K.
Regulatory Requirements: Exporting Tobramycin to Key Markets
What Sun Pharmaceutical Industries Ltd must comply with to export Tobramycin to its top destination countries
United States — FDA
Approval Process
ANDA (Abbreviated New Drug Application) for generics. Indian manufacturing site must pass FDA pre-approval inspection. Drug Master File (DMF) required for APIs.
Timeline: 10–18 months for ANDA approval
GMP & Export Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA
Drug Listing with FDA; Export Certificate from CDSCO India; Import Alert screening via FDA PREDICT system
Note: Subject to FDA Import Alerts. Open Form 483 observations can block all exports from a facility.
Australia — TGA
Approval Process
Registration on Australian Register of Therapeutic Goods (ARTG). Bioequivalence and quality data per TGA guidelines.
Timeline: 10–14 months
GMP & Export Requirements
TGA GMP clearance; PIC/S-aligned inspection. PIC/S certificate from India may expedite.
TGA sponsor licence for Australian importer; GMP clearance per manufacturing site
Note: TGA participates in PIC/S mutual recognition.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Sun Pharmaceutical Industries Ltd Compare to Nearest Tobramycin Exporters?
Exporters ranked immediately above and below #11 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 7 | SOMERSET THERAPEUTICS LIMITED | $1.5M | 62 | 1 | $24.8K |
| 6 | GLAND PHARMA LIMITED | $850.0K | 17 | 2 | $50.0K |
| 11 | SUN PHARMACEUTICAL INDUSTRIES LTD ★ | $800.0K | 16 | 2 | $50.0K |
| 12 | ALEMBIC PHARMACEUTICALS LIMITED | $650.0K | 13 | 1 | $50.0K |
| 14 | WINTAC LIMITED | $625.2K | 22 | 1 | $28.4K |
Sun Pharmaceutical Industries Ltd ranks #11 among 283 Indian Tobramycin exporters. Average shipment value of $50.0K compared to the market average of $73.4K. The closest competitors by value are SOMERSET THERAPEUTICS LIMITED and GLAND PHARMA LIMITED.
Which Indian Ports Ship Tobramycin Exports?
| Port | Shipments | % Share |
|---|---|---|
| DELHI AIR CARGO ACC (INDEL4) | 454 | 17.0% |
| SAHAR AIR CARGO ACC (INBOM4) | 329 | 12.3% |
| DELHI AIR | 316 | 11.8% |
| SAHAR AIR | 298 | 11.1% |
| NHAVA SHEVA SEA (INNSA1) | 93 | 3.5% |
| CHENNAI AIR CARGO ACC (INMAA4) | 88 | 3.3% |
| Delhi Air | 86 | 3.2% |
| Bombay Air | 79 | 3.0% |
Market Intelligence
Latest developments and market context
Detailed market intelligence for Tobramycin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Tobramycin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Sun Pharmaceutical Industries Ltd matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 93 individual customs records matching Sun Pharmaceutical Industries Ltd exporting Tobramycin, covering 41 formulations to 4 countries via 10 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 134+ countries, 580+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Tobramycin Export Data from Sun Pharmaceutical Industries Ltd
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Sun Pharmaceutical Industries Ltd's Tobramycin exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Sun Pharmaceutical Industries Ltd
Company Profile
0 products · $0 total trade · 0 categories
Tobramycin Stats
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Sun Pharmaceutical Industries Ltd.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Tobramycin. For current shipment-level data, contact TransData Nexus.